Test Code CTP10 Catecholamine Fractionation, Standing, Plasma, Free
Specimen Required
Only orderable as part of a profile. For more information see CATPA / Catecholamine, Endocrine Study, Plasma.
Patient Preparation:
1. Discontinue drugs that release epinephrine, norepinephrine, or dopamine, or hinder their metabolism, for at least 1 week before obtaining the specimen (see Cautions for details). If this is not possible for medical reasons, contact the laboratory and discuss whether a shorter drug-withdrawal period may be possible in a particular case.
2. Unless the purpose of the measurement is drug monitoring, discontinue any epinephrine, norepinephrine, or dopamine injections/infusions for at least 12 hours before specimen draw.
3. The patient must refrain from eating, using tobacco, and drinking caffeinated beverages for at least 4 hours before the specimen is collected.
Supplies: Catecholamine tubes containing EDTA-sodium metabisulfite solution (T066) (tubes have a 6-month. expiration time)
Collection Container/Tube:
Preferred: 10-mL Catecholamine tubes containing EDTA-sodium metabisulfite solution
Acceptable: 6-mL Catecholamine tubes containing EDTA-sodium metabisulfite solution
Submission Container/Tube: Plastic vial
Specimen Volume: 3 mL per collection
Collection Instructions:
1. Drawing from a catheter is required.
2. Calm the patient by giving complete instructions and reassurance regarding the procedure.
3. Insert an indwelling intravenous catheter. Flush with 3 mL of saline, using positive pressure.
4. Have the patient rest for 30 minutes in the supine position in a quiet room.
5. At the end of the 30 minutes, withdraw and discard a minimum of 3 mL of blood to remove the saline out of the catheter.
6. If provocative sampling (eg, standing specimen) is required, perform provocative maneuver immediately after obtaining supine specimen. Obtain standing specimen immediately.
7. For each specimen, draw blood into the chilled EDTA-sodium metabisulfite 10-mL tube.
8. Specimen must remain at refrigerated temperature during processing and transport.
9. Separate plasma in a refrigerated centrifuge within 30 minutes of draw.
10. Freeze specimen immediately.
Useful For
Diagnosis of pheochromocytoma and paraganglioma in specimens collected from individuals in a standing position, as an auxiliary test to fractionated plasma and urine metanephrine measurements
Diagnosis and follow-up of patients with neuroblastoma and related tumors, as an auxiliary test to urine vanillylmandelic acid and homovanillic acid measurements
Evaluation of patients with autonomic dysfunction/failure or autonomic neuropathy
Method Name
Only orderable as part of a profile. For more information see CATPA / Catecholamine, Endocrine Study, Plasma.
Liquid Chromatography Tandem Mass Spectrometry (LC-MS/MS)
Reporting Name
Catecholamine, Fract, Standing, PSpecimen Type
Plasma EDTA MetaSpecimen Stability Information
Specimen Type | Temperature | Time | Special Container |
---|---|---|---|
Plasma EDTA Meta | Frozen | 28 days |
Reject Due To
Gross hemolysis | Reject |
Gross lipemia | OK |
Gross icterus | OK |
Clinical Information
The catecholamines (dopamine, epinephrine, and norepinephrine) are derived from tyrosine via a series of enzymatic conversions. All 3 catecholamines are important neurotransmitters in the central nervous system and also play a crucial role in the autonomic regulation of many homeostatic functions, namely, vascular tone, intestinal and bronchial smooth muscle tone, cardiac rate and contractility, and glucose metabolism. Their actions are mediated via alpha and beta adrenergic and dopamine receptors, all existing in several subforms. The 3 catecholamines overlap but differ in their receptor activation profile and consequent biological actions. The systemically circulating fraction of the catecholamines is derived almost exclusively from the adrenal medulla, with small contributions from sympathetic ganglia.
Catecholamines are normally present in the plasma in minute amounts but levels can increase dramatically and rapidly in response to change in posture, environmental temperature, physical and emotional stress, hypovolemia, blood loss, hypotension, hypoglycemia, and exercise.
In patients with pheochromocytoma (a potentially curable tumor of catecholamine producing cells of the adrenal medulla), or less commonly, paraganglioma (a tumor of the sympathetic ganglia that also produces catecholamine), plasma catecholamine levels may be continuously or episodically elevated. This results in episodic or sustained hypertension and in intermittent attacks of palpitations, cardiac arrhythmias, headache, sweating, pallor, anxiety, tremor, and nausea. Intermittent or continuous elevations of the plasma levels of 1 or several of the catecholamines may be observed in patients with neuroblastoma and related tumors (ganglioneuroblastomas and ganglioneuromas) and, very occasionally, in other neuroectodermal tumors.
At the other end of the spectrum, inherited and acquired syndromes of autonomic dysfunction/failure and autonomic neuropathies are characterized by either inadequate production of 1 or several of the catecholamines or by insufficient release of catecholamines upon appropriate physiological stimuli (eg, change in posture from supine to standing, cold exposure, exercise, stress).
Reference Values
Only orderable as part of a profile. For more information see CATPA / Catecholamine, Endocrine Study, Plasma.
Report Available
2 to 6 daysPerforming Laboratory
Mayo Clinic Laboratories in RochesterTest Classification
This test was developed and its performance characteristics determined by Mayo Clinic in a manner consistent with CLIA requirements. It has not been cleared or approved by the US Food and Drug Administration.CPT Code Information
82384
Day(s) Performed
Monday through Friday